INS and obesity disorder: Novel evidence has recently reinforced the role of insulin as risk factor; however, it appears clear that there is an unequivocal need to understand how the insulin pathway increases the risk of RCC and to discover further biological pathways as well as obesity-related mechanisms involved in RCC growth.